Re: comment on: Miedany et al. response letter: Beyond the symptoms: personalizing giant cell arteritis care through multidimensional patient reported outcome measure. Volume 75, December 2025, 152844

ElsevierVolume 77, April 2026, 152919Seminars in Arthritis and RheumatismAuthor links open overlay panelJC Robson a b, J Dawson c, SL Mackie d e, M Ndosi a bShow moreAccess through your organization

Check access to the full text by signing in through your organization.

Access through your organizationSection snippetsCRediT authorship contribution statement

JC Robson: Conceptualization, Data curation, Methodology, Writing – original draft, Writing – review & editing. J Dawson: Conceptualization, Methodology, Writing – review & editing. SL Mackie: Conceptualization, Methodology, Writing – review & editing. M Ndosi: Conceptualization, Methodology, Writing – review & editing.

Declaration of competing interest

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Joanna C Robson reports a relationship with AstraZeneca that includes: consulting or advisory. Joanna C Robson reports a relationship with Vifor Pharma that includes: consulting or advisory, funding grants, non-financial support, speaking and lecture fees, and travel reimbursement. Joanna C Robson reports a relationship with Sanofi that includes: funding grants.

References (8)

There are more references available in the full text version of this article.

View full text

© 2026 Published by Elsevier Inc.

Comments (0)

No login
gif